Global Prostate Cancer Therapeutics Market to 2020

© Renub Research Page 1 of 14

Global Prostate Cancer Therapeutics Market to 2020

Renub Researchwww.renub.com

Published: November, 2015Copyright © 2015 Renub Research – All Rights Reserved

© Renub Research Page 2 of 14

Global Prostate Cancer Therapeutics Market Overview

The prostate cancer drugs market is expected to nearly double by 2020, due to the

introduction of new, more expensive drugs. Prostate Cancer is the most frequently diagnosed

cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it

ranks sixth in terms of cancer–related mortality in men. The prostate cancer market has a huge

demand for new and novel drugs that address unmet needs such as improved survival time, less

toxicity, increased progression free survival, increased effectiveness, and lower cost. The

global market for the prostate cancer therapeutics market is increasing, driven primarily by

the growth in the hormone–refractory prostate cancer therapeutics market. Although, the

prostate cancer market faces some hindrances such as the high cost of prostate cancer drugs,

the market for prostate cancer drugs is likely to rise in the future.

Global Prostate Cancer Drugs Analysis: Zytiga was the leading prostate cancer drugs in 2014

being followed by Xtandi drugs. In prostate cancer drugs market, Leuplin and Zoladex stand at

the third and fourth position respectively in 2014, while Lupron stands at the fifth position in

the same year. Bayer's cancer drug Xofigo is also increasing its market share. Decapeptyl,

Taxotere, Jevtana and Provenge are the other popular prostate cancer drugs in the global

market.

Renub Research report titled “Global Prostate Cancer Therapeutics Market to 2020”

provides a comprehensive assessment of the fast–evolving, high–growth of Prostate Cancer

Therapeutics Market. This 80 page report with 35 Figures and 2 Tables analyses the Prostate

Cancer Therapy Drugs Market, driving factors and challenges for prostate cancer market

landscape.

The report covers the following:

1. Global Prostate Cancer – Hormonal Therapy Drugs Market

Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists

1. Zytiga

© Renub Research Page 3 of 14

2. Gonax

Luteinizing Hormone–Releasing Hormone (LHRH) Analogs

1. Lupron

2. Zoladex

3. Decapeptyl

4. Eligard

5. Vantas

6. Leuplin

Anti–Androgens

1. Casodex

2. Xtandi or MDV3100

3. Xtandi US or MDV3100

2. Global Prostate Cancer Chemotherapy Drugs Market

1. Taxotere

2. Jevtana

3. Global Prostate Cancer Immunotherapy Drugs Market

1. Provenge

4. Global Prostate Cancer Targeted Therapy Drugs Market

1. Xofigo or Alpharadin

© Renub Research Page 4 of 14

Data Sources

This report is built using data and information sourced from proprietary databases, primary and

secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–

printable sources like search engines, News websites, Government Websites, Trade Journals,

White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,

Industry Portals, Industry Associations and access to more than 500 paid databases.

© Renub Research Page 5 of 14

About Us

RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long–term experience especially in

international Business–to–Business Researches, Surveys, Business and Consulting. Throughout

the years we have acquired expertise in most market sectors, including Information Technology

(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,

Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer

Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and

Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information

Technology, Environmental Science and many more. Our research help make the business

decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We

support many blue chip companies by providing them findings and perspectives across a wide

range of markets. Our research reports offer a blend of information insight, analysis and

forecasting that is essential in today’s ultra–competitive markets.

For more information on us or to view any of our sample work you can mail

us at [email protected]

© Renub Research Page 6 of 14

Published

By

RReennuubb RReesseeaarrcchh

1st Floor,

C – 86, Sector – 10

Noida – 201301

Phone: +91–120–421–9822, 254–5750 (India)

+1–678–302–0700 (USA)

Fax : +91–120–424–9780

Email: [email protected]

www.renub.com

© Global Prostate Cancer Therapeutics Market to 2020

Renub Research, 2015

Edition 1.0

All rights reserved. This publication is protected

by copyright. No part of it may be reproduced, stored

in a retrieval system or transmitted, in any form or by

any means, electronic mechanical, photocopying,

recording or otherwise without the prior written

permission of the publishers

© Renub Research Page 7 of 14

Table of Contents

1. Executive Summary

2. Prostate Cancer – Overview

2.1 Prostate Cancer Introduction

2.2 Risk Factors

2.2.1 Age

2.2.2 Race

2.2.3 Family History/Genetics

2.2.4 Diet/Lifestyle Factors

2.2.5 Obesity

2.2.6 Infection/Inflammation of the Prostate Gland

2.3 Disease Symptoms

2.4 Diagnosis

2.4.1 Digital Rectal Exam (DRE)

2.4.2 Prostate Specific Antigen (PSA) Blood Test

2.4.3 Prostate Ultrasound and Biopsy

2.4.4 Bone Scan

2.4.5 CT Scan & MRI

2.4.6 PET & SPECT Scan

2.4.7 Lymph Node Biopsy

2.4.8 ProstaScint Scan

2.5 Stages of Prostate Cancer

2.5.1 Stage I

2.5.2 Stage II

2.5.3 Stage III

2.5.4 Stage IV

3. Global Prostate Cancer Drugs Market

4. Global Prostate Cancer Incidence

© Renub Research Page 8 of 14

5. Global Prostate Cancer Drugs Market Share

6. Global Prostate Cancer – Hormonal Therapy Drugs Sales & Forecast to 2020

6.1 Luteinizing Hormone – Releasing Hormone (LHRH) Antagonists

6.1.1 Zytiga

6.1.2 Gonax / Firmagon

6.2 Luteinizing Hormone – Releasing Hormone (LHRH) Analogs

6.2.1 Lupron

6.2.2 Zoladex

6.2.3 Decapeptyl

6.2.4 Eligard

6.2.5 Vantas

6.2.6 Leuplin

6.3 Anti – Androgens

6.3.1 Casodex

6.3.2 Xtandi or MDV3100

6.3.3 Xtandi US or MDV3100

7. Global Prostate Cancer – Chemotherapy Drugs Market

7.1 Taxotere

7.2 Jevtana

8. Global Prostate Cancer – Immunotherapy Drugs Market

8.1 Provenge

9. Global Prostate Cancer – Targeted Therapy Drugs Market

9.1 Xofigo or Alpharadin

10. Global Prostate Cancer Market – Driving Factors

10.1 Introduction of Innovative Drugs

10.2 Advancement in Oncology Therapeutic Area

10.3 Development in Genomics & Proteomics

© Renub Research Page 9 of 14

11. Global Prostate Cancer Market – Challenges

11.1 Costly Prostate Cancer Drugs

11.2 Adverse Events of Treatment

11.3 Low Success Rate for Oncology Drugs

© Renub Research Page 10 of 14

List of Figures:

Figure 3–1: Global – Prostate Cancer Drugs Market (Million US$), 2010 – 2014

Figure 3–2: Global – Forecast for Prostate Cancer Drugs Market (Million US$), 2015 – 2020

Figure 4–1: Global – Prostate Cancer Incidence (Number), 2007 – 2014

Figure 4–2: Global – Forecast for Prostate Cancer Incidence (Number), 2015 – 2020

Figure 6–1: Global – Zytiga Drugs Sales (Million US$), 2011 – 2014

Figure 6–2: Global – Forecast for Zytiga Drugs Sales (Million US$), 2015 – 2020

Figure 6–3: Global – Gonax/ Firmagon Drugs Sales (Million US$), 2012 – 2014

Figure 6–4: Global – Forecast for Gonax Drugs Sales (Million US$), 2015 – 2020

Figure 6–5: Global – Lupron Drugs Sales (Million US$), 2009 – 2014

Figure 6–6: Global – Forecast for Lupron Drugs Sales (Million US$), 2015 – 2020

Figure 6–7: Global – Zoladex Drugs Sales (Million US$), 2009 – 2014

Figure 6–8: Global – Forecast for Zoladex Drugs Sales (Million US$), 2015 – 2020

Figure 6–9: Global – Decapeptyl Drugs Sales (Million US$), 2009 – 2014

Figure 6–10: Global – Forecast for Decapeptyl Drugs Sales (Million US$), 2015 – 2020

Figure 6–11: Global – Eligard Drug Sales (Million US$), 2009 – 2014

Figure 6–12: Global – Forecast for Eligard Drug Sales (Million US$), 2015 – 2020

Figure 6–13: Global – Vantas Drugs Sales (Million US$), 2009 – 2014

Figure 6–14: Global – Forecast for Vantas Drugs Sales (Million US$), 2015 – 2020

Figure 6–15: Global – Leuplin Drugs Sales (Million US$), 2009 – 2014

Figure 6–16: Global – Forecast for Leuplin Drugs Sales (Million US$), 2015 – 2020

Figure 6–17: Global – Casodex Drug Sales (Million US$), 2009 – 2014

Figure 6–18: Global – Forecast for Casodex Drug Sales (Million US$), 2015 – 2020

Figure 6–19: Global – Xtandi or MDV3100 Drug Sales (Million US$), 2012 – 2014

Figure 6–20: Global – Forecast for Xtandi or MDV3100 Drug Sales (Million US$), 2015 – 2020

Figure 6–21: Global – Xtandi US or MDV3100 Drug Sales (Million US$), 2012 – 2014

Figure 6–22: Global – Forecast for Xtandi US or MDV3100 Drug Sales (Million US$), 2015 – 2020

Figure 7–1: Global – Taxotere Drug Sales (Million US$), 2011 – 2014

Figure 7–2: Global – Forecast for Taxotere Drug Sales (Million US$), 2015 – 2020

Figure 7–3: Global – Jevtana Drug Sales (Million US$), 2010 – 2014

Figure 7–4: Global – Forecast for Jevtana Drug Sales (Million US$), 2015 – 2020

Figure 8–1: Global – Provenge Drugs Sales (Million US$), 2011 – 2014

© Renub Research Page 11 of 14

Figure 8–2: Global – Forecast for Provenge Drugs Sales (Million US$), 2015 – 2020

Figure 9–1: Global – Xofigo or Alpharadin Drug Sales (Million US$), 2013 – 2014

Figure 9–2: Global – Forecast for Xofigo or Alpharadin Drug Sales (Million US$), 2015 – 2020

Figure 11–1: Therapeutic Categories – Overall Success Rate from Phase 1 through Likelihood of Approval

(Percent), 2004 – 2010

List of Tables:

Table 5–1: Global – Prostate Cancer Drugs Market Share (Percent), 2011 – 2014

Table 5–2: Global – Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 – 2020

© Renub Research Page 12 of 14

Order Form

Scan and e-mail this page to [email protected], alternatively one can also write the Contact

Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

[email protected]

Format

1. Report Title: Global Prostate Cancer Therapeutics Market to 2020

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1200 US$ 1300 US$ 1300 US$ 1800

For ordering this report: Easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):

http://www.renub.com/global-prostate-cancer-therapeutics-market-to-2020-487-p.php

© Renub Research Page 13 of 14

Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India

Contact Information

First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:

© Renub Research Page 14 of 14

3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor

C-86, Sector -10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: https://www.facebook.com/RenubResearch

LinkedIn: https://www.linkedin.com/company/renub-research

Twitter: https://twitter.com/renubresearch